Effectiveness and Long-Term Side Effects Associated with Hormonal Therapy in Patients with Polycystic Ovarian Disease (PCOD)

ABSTRACTPolycystic Ovarian Disease (PCOD), commonly referred to as Polycystic Ovary Syndrome (PCOS), is aheterogeneous endocrine disorder associated with menstrual dysfunction, hyperandrogenic manifestations,metabolic abnormalities, reproductive difficulties, and psychological burden. Hormonal therapy is widely usedto control menstrual irregularity and androgen-related manifestations, but long-term pharmacologicalmanagement also requires attention to tolerability, adverse drug reactions (ADRs), body-weight changes,treatment satisfaction, and other possible side effects.The present research paper reformulates the study framework and illustrative Chapter 5 findings contained in theuploaded synopsis. The proposed clinical design is a cross-sectional observational study among 100 adultfemale patients with PCOD receiving hormonal therapy for at least three months. Data domains include age,BMI, duration of PCOD, treatment regimen, menstrual regularity, acne, hirsutism, body-weight change, ADRs,ADR severity, overall response, safety, tolerability, and patient satisfaction.In the illustrative dataset, 42% of participants were aged 21–25 years; 38% were overweight and 27% wereobese. Combined oral contraceptive pills represented 45% of treatment regimens. Improvement was reported formenstrual regularity in 78%, acne in 65%, and hirsutism in 58% of patients. Forty-six percent reported at leastone ADR, with headache being the most frequently listed reaction. Among patients with ADRs, 67.39% wereclassified as mild, 30.43% moderate, and 2.17% severe. Overall, 75% were categorized as having good-toexcellent treatment response and 75% were satisfied or very satisfied.The findings support the importance of assessing therapeutic effectiveness together with safety and tolerability.However, because the source document identifies the clinical dataset as illustrative and non-randomized, nocausal effectiveness claim or statistically significant comparison between regimens should be inferred fromthese results.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-09
DOI
https://doi.org/10.5281/zenodo.22668520
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness and Long-Term Side Effects Associated with Hormonal Therapy in Patients with Polycystic Ovarian Disease (PCOD)

Sushmita Saha, Pranshu Tangri, Meenakshi Ghildiyal
Zenodo (CERN European Organization for Nuclear Research)
Ovarian function and disorders
article

Effectiveness and Long-Term Side Effects Associated with Hormonal Therapy in Patients with Polycystic Ovarian Disease (PCOD)

Sushmita Saha, Pranshu Tangri, Meenakshi Ghildiyal
article en

Abstract

ABSTRACTPolycystic Ovarian Disease (PCOD), commonly referred to as Polycystic Ovary Syndrome (PCOS), is aheterogeneous endocrine disorder associated with menstrual dysfunction, hyperandrogenic manifestations,metabolic abnormalities, reproductive difficulties, and psychological burden. Hormonal therapy is widely usedto control menstrual irregularity and androgen-related manifestations, but long-term pharmacologicalmanagement also requires attention to tolerability, adverse drug reactions (ADRs), body-weight changes,treatment satisfaction, and other possible side effects.The present research paper reformulates the study framework and illustrative Chapter 5 findings contained in theuploaded synopsis. The proposed clinical design is a cross-sectional observational study among 100 adultfemale patients with PCOD receiving hormonal therapy for at least three months. Data domains include age,BMI, duration of PCOD, treatment regimen, menstrual regularity, acne, hirsutism, body-weight change, ADRs,ADR severity, overall response, safety, tolerability, and patient satisfaction.In the illustrative dataset, 42% of participants were aged 21–25 years; 38% were overweight and 27% wereobese. Combined oral contraceptive pills represented 45% of treatment regimens. Improvement was reported formenstrual regularity in 78%, acne in 65%, and hirsutism in 58% of patients. Forty-six percent reported at leastone ADR, with headache being the most frequently listed reaction. Among patients with ADRs, 67.39% wereclassified as mild, 30.43% moderate, and 2.17% severe. Overall, 75% were categorized as having good-toexcellent treatment response and 75% were satisfied or very satisfied.The findings support the importance of assessing therapeutic effectiveness together with safety and tolerability.However, because the source document identifies the clinical dataset as illustrative and non-randomized, nocausal effectiveness claim or statistically significant comparison between regimens should be inferred fromthese results.

Zenodo (CERN European Organization for Nuclear Research)
Institute of Management Technology (IN)
Good health and well-being
Openalex Percentile: Top 8%
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.